E R Kern Selected Research

Infections

10/2008	NIH consensus development statement on management of hepatitis B.
8/2001	Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.
7/2001	Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue.
4/2001	Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
1/2001	In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
1/2001	Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
9/2000	Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection.
6/2000	In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections.
1/2000	Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice.
1/2000	Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E R Kern Research Topics

Disease

10	Infections 10/2008 - 01/2000
1	Liver Failure 10/2008
1	Chronic Hepatitis B 10/2008
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2008
1	Fibrosis (Cirrhosis) 10/2008
1	Hepatitis 10/2008
1	Hepatocellular Carcinoma (Hepatoma) 10/2008
1	Communicable Diseases (Infectious Diseases) 10/2008
1	Sialadenitis 04/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2001
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/2000
1	Herpes Simplex 09/2000
1	Herpesviridae Infections (Herpesvirus Infection) 06/2000
1	Inflammation (Inflammations) 03/2000
1	Cytomegalovirus Infections (Inclusion Disease) 01/2000

Drug/Important Bio-Agent (IBA)

2	Retinaldehyde (Retinal)IBA 07/2001 - 01/2001
2	Antiviral Agents (Antivirals)IBA 01/2001 - 01/2000
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2001 - 06/2000
2	ProdrugsIBA 06/2000 - 01/2000
2	Acyclovir (Aciclovir)FDA LinkGeneric 01/2000 - 01/2000
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2008
1	Immunoglobulins (Immunoglobulin)IBA 10/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2008
1	Pharmaceutical PreparationsIBA 08/2001
1	RMP 7IBA 08/2001
1	BradykininIBA 08/2001
1	Fas Ligand Protein (Fas Ligand)IBA 04/2001
1	1- O- hexadecyl- propanediol- 3- phospho- ganciclovirIBA 01/2001
1	1- O- hexadecylpropanediol- 3- phospho- penciclovirIBA 01/2001
1	SolutionsIBA 09/2000
1	Local Anti-Infective Agents (Antiseptics)IBA 09/2000
1	BRI 2999IBA 09/2000
1	Dendrimers (Dendrons)IBA 09/2000
1	BRI 6741IBA 09/2000
1	methylenecyclopropaneIBA 06/2000
1	NucleosidesIBA 06/2000
1	AutoantibodiesIBA 03/2000
1	penciclovir (Denavir)FDA Link 01/2000
1	LipidsIBA 01/2000
1	Thymidine KinaseIBA 01/2000
1	acyclovir monophosphateIBA 01/2000
1	1-O-hexadecylpropanediol-3-p-acyclovirIBA 01/2000

Therapy/Procedure

1	Liver Transplantation 10/2008
1	Drug Therapy (Chemotherapy) 10/2008
1	Therapeutics 10/2008
1	Organ Transplantation 01/2001